m I added one comma in the first sentence, directly before the phrase "in humans", and I also added one comma at the end of this same phrase. This classifies the phrase "in humans" as being a non-restrictive appositive.
Line 1:
Line 1:
{{Infobox_gene}}
{{Infobox_gene}}
'''N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase''' is an [[enzyme]] that in humans is encoded by the ''B3GNT1'' [[gene]].<ref name="pmid9405606">{{cite journal | vauthors = Sasaki K, Kurata-Miura K, Ujita M, Angata K, Nakagawa S, Sekine S, Nishi T, Fukuda M | title = Expression cloning of cDNA encoding a human beta-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 94 | issue = 26 | pages = 14294–9 | date = December 1997 | pmid = 9405606 | pmc = 24948 | doi = 10.1073/pnas.94.26.14294 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: B3GNT1 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=11041| accessdate = }}</ref>
'''N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase''' is an [[enzyme]] that, in humans, is encoded by the ''B3GNT1'' [[gene]].<ref name="pmid9405606">{{cite journal | vauthors = Sasaki K, Kurata-Miura K, Ujita M, Angata K, Nakagawa S, Sekine S, Nishi T, Fukuda M | title = Expression cloning of cDNA encoding a human beta-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 94 | issue = 26 | pages = 14294–9 | date = December 1997 | pmid = 9405606 | pmc = 24948 | doi = 10.1073/pnas.94.26.14294 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: B3GNT1 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=11041| accessdate = }}</ref>
The B3GNT1gene encodes a β-1,4-glucuronyltransferase, designated B4GAT1, that transfers glucuronic acid towards both α- and β-anomers of xylose[3]. B4GAT1 is the priming enzyme for LARGE, a dual-activity glycosyltransferase that is capable of extending products of B4GAT1. Thus, B4GAT1 is involved in the initiation of the LARGE-dependent repeating disaccharide that is necessary for extracellular matrix protein binding to O-mannosylated α-dystroglycan that is lacking in secondary dystroglycanopathies.
Misidentification
The B3GNT1 gene was first reported to encode a member of the beta-1,3-N-acetylglucosaminyltransferase family and thought to be responsible for the synthesis of poly-N-acetyllactosamine[1], a determinant for the blood group i antigen. Thus, it was also known as iGNT.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (October 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Maruyama K, Sugano S (January 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.